Trials / Sponsors / Brenda Cooper, MD
Brenda Cooper, MD
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia | Phase 1 | 2018-05-22 |
| Completed | Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia Untreated Adult Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2009-07-01 |